NZ572359A - Use of selected lactic acid bacteria for reducing infantile colic - Google Patents

Use of selected lactic acid bacteria for reducing infantile colic

Info

Publication number
NZ572359A
NZ572359A NZ572359A NZ57235907A NZ572359A NZ 572359 A NZ572359 A NZ 572359A NZ 572359 A NZ572359 A NZ 572359A NZ 57235907 A NZ57235907 A NZ 57235907A NZ 572359 A NZ572359 A NZ 572359A
Authority
NZ
New Zealand
Prior art keywords
colic
cells
reuteri
strains
infants
Prior art date
Application number
NZ572359A
Other languages
English (en)
Inventor
Eamonn Connolly
Bo Mollstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38790468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ572359(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogaia Ab filed Critical Biogaia Ab
Priority to NZ596788A priority Critical patent/NZ596788A/xx
Publication of NZ572359A publication Critical patent/NZ572359A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NZ572359A 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic NZ572359A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ596788A NZ596788A (en) 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/446,628 US7374924B2 (en) 2006-06-05 2006-06-05 Use of selected lactic acid bacteria for reducing infantile colic
PCT/SE2007/050371 WO2007142596A1 (en) 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic

Publications (1)

Publication Number Publication Date
NZ572359A true NZ572359A (en) 2011-12-22

Family

ID=38790468

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ572359A NZ572359A (en) 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic
NZ596788A NZ596788A (en) 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ596788A NZ596788A (en) 2006-06-05 2007-05-30 Use of selected lactic acid bacteria for reducing infantile colic

Country Status (20)

Country Link
US (3) US7374924B2 (https=)
EP (1) EP2040722B1 (https=)
JP (3) JP4520531B2 (https=)
KR (2) KR101030661B1 (https=)
CN (2) CN101374533B (https=)
AU (2) AU2007200434B2 (https=)
BR (1) BRPI0710944B8 (https=)
CA (1) CA2650546C (https=)
DK (1) DK2040722T3 (https=)
GE (1) GEP20125480B (https=)
HU (1) HUE026416T2 (https=)
IL (1) IL194779A0 (https=)
MX (1) MX2008014869A (https=)
MY (1) MY162708A (https=)
NZ (2) NZ572359A (https=)
RU (1) RU2435844C2 (https=)
SI (1) SI2040722T1 (https=)
UA (1) UA93911C2 (https=)
WO (1) WO2007142596A1 (https=)
ZA (1) ZA200809531B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
SG188887A1 (en) * 2008-03-14 2013-04-30 Nestec Sa Synbiotic mixture
CA2742476A1 (en) * 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
WO2011012655A1 (en) 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
NL2004101C2 (en) * 2010-01-15 2011-07-18 Friesland Brands Bv Ruminant il-10 and use in modulating immune response.
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
KR101706100B1 (ko) * 2011-12-15 2017-02-15 삼성전자주식회사 성형한계선도 획득용 시험장치
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US10265351B2 (en) * 2013-08-09 2019-04-23 Ab-Biotics, S.A. Probiotic for infantile colic
US20160334391A1 (en) 2014-01-23 2016-11-17 Biogaia Ab Selection of Agents Modulating Gastrointestinal Pain
EP3212208B1 (en) * 2014-10-29 2021-03-03 Biogaia AB Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
JP6529835B2 (ja) * 2015-06-23 2019-06-12 株式会社フィス 樹状細胞活性化剤
CN105219683B (zh) * 2015-11-04 2018-03-13 广东省农业科学院动物科学研究所 一株具有益生特征的罗伊氏乳杆菌菌株及其应用
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN106497840B (zh) * 2016-11-07 2019-06-21 江南大学 一种定向分离免疫调节性肠道乳杆菌的方法
EP3827102A1 (en) * 2018-07-24 2021-06-02 Biogaia AB Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
IL305597B2 (en) * 2018-07-24 2024-08-01 Biogaia Ab Selection and use of melatonin-supporting bacteria to reduce infantile tinea
JP7556881B2 (ja) * 2019-04-17 2024-09-26 バイオガイア エイビー プロバイオティック細菌の治療用マイクロベシクル
WO2022203379A1 (ko) * 2021-03-26 2022-09-29 서울대학교산학협력단 유산균의 생리활성 효능 증진용 조성물
CN117925484B (zh) * 2024-03-19 2024-07-09 山东中科嘉亿生物工程有限公司 一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用
WO2025206977A1 (ru) * 2024-03-29 2025-10-02 Александр Владимирович Синица Штамм бактерий lactobacillus reuteri, подавляющий активность helicobacter pylori

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
ES2199305T3 (es) 1995-12-21 2004-02-16 Biogaia Ab Uso de lactobacillus reuteri para inhibir criptosporidiosis en mamiferos.
US5837238A (en) 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
MXPA05003743A (es) * 2002-10-18 2005-06-17 Biogaia Ab Metodo para mejorar la funcion inmunologica en mamiferos utilizando cepas de lactobacillus reuteri.
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
ES2326481T3 (es) * 2003-06-23 2009-10-13 Nestec S.A. Formula para recien nacidos o formula de continuacion.
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic

Also Published As

Publication number Publication date
HK1125840A1 (en) 2009-08-21
HUE026416T2 (en) 2016-07-28
US20120121564A1 (en) 2012-05-17
US9057112B2 (en) 2015-06-16
AU2010202976B2 (en) 2012-12-20
RU2008147883A (ru) 2010-07-20
CN102488717A (zh) 2012-06-13
MY162708A (en) 2017-07-14
EP2040722A1 (en) 2009-04-01
GEP20125480B (en) 2012-04-25
BRPI0710944B8 (pt) 2021-05-25
US7374924B2 (en) 2008-05-20
NZ596788A (en) 2013-03-28
BRPI0710944A2 (pt) 2017-04-18
US9340840B2 (en) 2016-05-17
ZA200809531B (en) 2010-03-31
WO2007142596A1 (en) 2007-12-13
BRPI0710944B1 (pt) 2020-12-29
KR101030661B1 (ko) 2011-04-20
CN101374533A (zh) 2009-02-25
EP2040722A4 (en) 2010-06-02
MX2008014869A (es) 2008-12-05
JP2009539371A (ja) 2009-11-19
JP5865283B2 (ja) 2016-02-17
US20080131414A1 (en) 2008-06-05
DK2040722T3 (en) 2016-02-01
JP2010202654A (ja) 2010-09-16
RU2435844C2 (ru) 2011-12-10
EP2040722B1 (en) 2015-11-11
CA2650546C (en) 2011-08-02
KR20090015903A (ko) 2009-02-12
JP4520531B2 (ja) 2010-08-04
AU2010202976A1 (en) 2010-08-05
KR20100080565A (ko) 2010-07-08
AU2007200434B2 (en) 2010-09-02
SI2040722T1 (sl) 2016-02-29
CN101374533B (zh) 2012-02-01
CA2650546A1 (en) 2007-12-13
JP2013173749A (ja) 2013-09-05
CN102488717B (zh) 2018-03-27
IL194779A0 (en) 2009-08-03
US20070280913A1 (en) 2007-12-06
UA93911C2 (ru) 2011-03-25
AU2007200434A1 (en) 2007-12-20
KR101308865B1 (ko) 2013-09-17

Similar Documents

Publication Publication Date Title
CA2650546C (en) Use of selected lactic acid bacteria for reducing infantile colic
CN101744841B (zh) 用于治疗炎性疾病的双歧杆菌
EP1868596B1 (en) Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
US20060233752A1 (en) Method for treating or preventing systemic inflammation in formula-fed infants
AU2013201542A1 (en) Use of selected lactic acid bacteria for reducing infantile colic
TWI351962B (en) Use of selected lactic acid bacteria for reducing
HK1173944A (en) Use of selected lactic acid bacteria for reducing infantile colic
HK1125840B (en) Use of selected lactic acid bacteria for reducing infantile colic
HK1173944B (en) Use of selected lactic acid bacteria for reducing infantile colic

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 MAY 2017 BY LEA SKYLLERSTEDT

Effective date: 20140520

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2018 BY CPA GLOBAL(PATRAFEE)

Effective date: 20170516

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2019 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20180518

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2020 BY CPA GLOBAL(PATRAFEE) AB

Effective date: 20190508

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2021 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20200525

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2022 BY CAMILLA WELLIN / CPA GLOBAL

Effective date: 20210504

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2023 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE

Effective date: 20220430

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2024 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20230504

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2025 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20240512

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2026 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20250509